- (2-Hydroxyethyl)diisopropylammonium chloride and its derivatives
-
The crystal structure of the title compound, C8H20NO+·-Cl-, (I), and the structures of its derivatives, (2-chloroethyl)diisopropylammonium chloride, C8H19ClN+·Cl-, (II), and diisopropyl(2-mercaptoethyl)ammonium chloride, C8H20NS+·Cl-, (III), are described. The conformations of the isopropyl groups in (II) (gauche-gauche) are different from those in (I) and (III) (both gauche-trans). The structures are stabilized by hydrogen bonds of the type Y-H...Cl (Y = N, O, S) and C-H...X (X = Cl, S).
- Mahmoudkhani, Amir Hossein,Langer, Vratislav
-
-
Read Online
- The preparation method of N, N - diisopropylethylenediamine. Preparation method of
-
N, N -isopropyl N chloroethylamine hydrochloride and the urotropine are reacted in an organic solvent to obtain N - and N diisopropyltripropylestamine quaternary ammonium salt; and the method comprises the following steps: N - reacting with the urotropine in an organic solvent to obtain the quaternary ammonium salt.2 - N - N. N, N - Diisopropyltriprolol quaternary ammonium salt and concentrated hydrochloric acid were reacted in an organic solvent to give N, N - diisopropylethylamine. To the preparation method, safety risks caused by high-pressure production routes are avoided, the quality risks caused by dimer impurities are avoided, environmental pollution is avoided, raw materials are economical and easy to obtain, production cost is low, and good economic benefits are achieved.
- -
-
Paragraph 0055; 0129-0138
(2021/08/25)
-
- Side chain impacts on pH- and thermo-responsiveness of tertiary amine functionalized polypeptides
-
The systemic investigation of the structural impacts of side chains on the pH- and thermo-responsiveness of tertiary amine functionalized poly(l-glutamate)s (TA-PGs) was carried out. The TA-PGs polymers were effectively synthesized by Cu(I)-catalyzed azide-alkyne cycloaddition click reaction of azido tertiary amines with poly(γ-propargyl-l-glutamate) (PPLG). Turbimetric measurements were performed to characterize the pH- and temperature-induced phase transition of TA-PGs in aqueous solution, which suggested a structural dependence of the properties on the N-substituted groups and the "linkers" between 1,2,3-triazole ring and the tertiary amine groups in the side chains. In detail, the pH responsive properties of TA-PGs were basically determined by the hydrophobicity of the N-substituted groups in the side chains and the pH transition point (pHt) decreased as the increasing hydrophobicity of the N-substituted groups, while the temperature-responsiveness of TA-PGs were affected by either the N-substituted groups or the "linkers." TA-PGs with a moderate N-substituted amine group (e.g., DEA, PR, and PD) or a branched "linker" (e.g., iso-propylene and 2-methylpropylene group) were more likely to express the LCST-type phase transition tuned by pH variation. These structure-property relationships revealed in this study would help to develop the applications of TA-PGs in smart drug delivery systems. Copyright
- Xiao, Chunsheng,Cheng, Yilong,Zhang, Yu,Ding, Jianxun,He, Chaoliang,Zhuang, Xiuli,Chen, Xuesi
-
p. 671 - 679
(2014/02/14)
-
- INDENOISOQUINOLINONE DERIVATIVES, MANUFACTURING METHOD AND MEDICAL USE THEREOF
-
Indenoisoquinolinone derivatives (I), the manufacturing method and the medical use thereof, which belong to pharmaceutical chemistry and organic chemistry field, are disclosed. These compounds can be used for treating several medical symptoms related to postmenopausal syndrome, uterine fibers deterioration and aortic smooth muscle cells proliferation, especially ER-(+) depend breast cancer. Meanwhile, these compounds can also be used for treating glioma and lung cancer, and have inhibiting effect on tumor metastasis effect on tumor metastasis.
- -
-
Paragraph 0072; 0073
(2013/04/13)
-
- 2,3-oxidosqualene-lanosterol cyclase inhibitors
-
The present invention relates to aminocyclohexanol derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
- -
-
-
- Compounds for the treatment of urinary incontinence
-
The invention concerns compounds having the formula I STR1 wherein Ar is a phenyl or benzyl group which is optionally substituted with hydroxy or alkoxy;R 1 is hydrogen, lower alkyl, lower alkoxy, hydroxy;R 2 is hydrogen, lower alkyl;R 3 is NR 4 R 5, whereinR 4 and R 5 which can be the same or different, are lower alkyl, or wherein R 4 and R 5, when taken together, form a ring with the nitrogen atom, whereby said ring optionally is substituted with lower alkyl;n is 0 or 1;m is 2 or 3 andtheir salts with physiologically acceptable acids and when the compounds can be in form of optical isomers, the racemic mixture and the individual isomers, for the treatment of disorders of the urinary bladder.
- -
-
-